Zobrazeno 1 - 10
of 689
pro vyhledávání: '"Terént, A"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background Oral anticoagulation therapy is recommended for the prevention of recurrent ischemic stroke in patients with atrial fibrillation (AF). Current guidelines do not provide evidence-based recommendations on optimal time-point to start
Externí odkaz:
https://doaj.org/article/ed63e386e9114bd7889c10515e0ce6b7
Autor:
Falkeborn, Margareta, Persson, Ingemar, Terént, Andreas, Bergström, Reinhold, Lithell, Hans, Naessén, Tord
Publikováno v:
Epidemiology, 1996 Jan 01. 7(1), 67-74.
Externí odkaz:
https://www.jstor.org/stable/3702759
Publikováno v:
In Journal of the American College of Cardiology 27 January 2015 65(3):225-232
Autor:
Rodu, Brad, Heavner, Karyn K., Phillips, Carl V., Hergens, Maria-Pia, Lambe, Mats, Pershagen, Göran, Terent, Andreas, Ye, Weimin
Publikováno v:
Epidemiology, 2009 May 01. 20(3), 468-470.
Externí odkaz:
https://www.jstor.org/stable/20485745
Publikováno v:
Epidemiology, 2008 Nov 01. 19(6), 794-799.
Externí odkaz:
https://www.jstor.org/stable/25662639
Autor:
Sandset, Else Charlotte, Bath, Philip MW, Boysen, Gudrun, Jatuzis, Dalius, Kõrv, Janika, Lüders, Stephan, Murray, Gordon D, Richter, Przemyslaw S, Roine, Risto O, Terént, Andreas, Thijs, Vincent, Berge, Eivind
Publikováno v:
In The Lancet 2011 377(9767):741-750
Autor:
Henriksson, Karin M., Farahmand, Bahman, Johansson, Saga, Åsberg, Signild, Terént, Andreas, Edvardsson, Nils
Publikováno v:
In International Journal of Cardiology 2010 141(1):18-23
Publikováno v:
Stroke. 48:1617-1623
Background and Purpose— Anticoagulant treatment is effective for preventing recurrent ischemic strokes in patients who have atrial fibrillation. This benefit is paid by a small increase of hemorrhages. Anticoagulant-related hemorrhages seem to incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ee2584c706089a77286d4e957e5ea9e
https://doi.org/10.1161/strokeaha.117.016902
https://doi.org/10.1161/strokeaha.117.016902
Publikováno v:
Journal of the American College of Cardiology. 65:225-232
Patients with atrial fibrillation (AF) and ≥1 point on the stroke risk scheme CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease, age 65-74 years, sex categor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2bce18016299fffa8656844c3c1a88
https://doi.org/10.1016/j.jacc.2014.10.052
https://doi.org/10.1016/j.jacc.2014.10.052